Obesity and greater body fat volume have been considered one of the primary adverse effects of insulin therapy in both Type 1 and 2 diabetes.[26,27] In the Diabetes Control and Complications Trial, whereas waist to hip ratios did not differ, T1DM patients receiving intensive insulin therapy significantly gained body weight compare to patients receiving conventional therapy. Here, INS is linked to Obesity.